Cargando…
Deciphering immune microenvironment and cell evasion mechanisms in human gliomas
Gliomas are considered one of the most malignant cancers in the body. Despite current therapies, including surgery, chemotherapy, and radiotherapy, these tumors usually recur with more aggressive and resistant phenotypes. Indeed, the survival following these conventional therapies is very poor, whic...
Autores principales: | Rafii, Soumaya, Kandoussi, Sarah, Ghouzlani, Amina, Naji, Oumayma, Reddy, Konala Priyanka, Ullah Sadiqi, Rizwan, Badou, Abdallah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235598/ https://www.ncbi.nlm.nih.gov/pubmed/37274252 http://dx.doi.org/10.3389/fonc.2023.1135430 |
Ejemplares similares
-
Immune Checkpoint Inhibitors in Human Glioma Microenvironment
por: Ghouzlani, Amina, et al.
Publicado: (2021) -
A(2A)R as a Prognostic Marker and a Potential Immunotherapy Target in Human Glioma
por: Rafii, Soumaya, et al.
Publicado: (2023) -
The Promising IgSF11 Immune Checkpoint Is Highly Expressed in Advanced Human Gliomas and Associates to Poor Prognosis
por: Ghouzlani, Amina, et al.
Publicado: (2021) -
The immune checkpoint VISTA exhibits high expression levels in human gliomas and associates with a poor prognosis
por: Ghouzlani, Amina, et al.
Publicado: (2021) -
NR2F6, a new immune checkpoint that acts as a potential biomarker of immunosuppression and contributes to poor clinical outcome in human glioma
por: Miftah, Hayat, et al.
Publicado: (2023)